Skip to content

Clinical trials

Phase 3 Lung Diseases trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: Sweden Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20142
20171
20193
20201
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
United Therapeutics2
Eli Lilly and Company1
Grifols Therapeutics LLC1
Hoffmann-La Roche1
Mallinckrodt1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases13
Respiratory Tract Diseases9
Bronchial Diseases5
Lung Diseases, Obstructive5
Asthma3
Pathologic Processes3
Pulmonary Disease, Chronic Obstructive3
COVID-192
Carcinoma, Bronchogenic2
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.